Table 1.
Below normal lung function (n = 12 364) | Normal lung function (n = 91 938) | Supernormal lung function (n = 3944) | |
---|---|---|---|
Age – years | 61·0 (51·8–69·3)* | 57·9 (47·9–67·2) | 53·4 (44·3–65·6)*,† |
Male sex – no. (%) | 5738 (46)* | 41 504 (45) | 1429 (36)*,† |
Weight – kg | 77·7 (66·7–90·0)* | 75·5 (65·7–86·1) | 73·5 (64·7–83·7)*,† |
Height – cm | 171 (165–178) | 171 (165–178) | 172 (165–179)*,† |
BMI – kg/m2 | 26·3 (23·4–29·7)* | 25·5 (23·2–28·3) | 24·9 (22·8–27·2)*,† |
Lung function | |||
FEV1 – L | 2·02 (1·58–2·47)* | 3·00 (2·49–3·60) | 3·90 (3·39–4·69)*,† |
FEV1% predicted –% | 69 (60–75)* | 98 (90–106) | 126 (122–132)*,† |
FVC – L | 2·94 (2·39–3·57)* | 3·87 (3·24–4·64) | 4·80 (4·19–5·81)*,† |
FVC% predicted –% | 78 (70–85)* | 101 (92–109) | 125 (119–132)*,† |
FEV1/FVC | 0·69 (0·61–0·76)* | 0·78 (0·74–0·82) | 0·81 (0·78–0·84)*,† |
Smoking information | |||
Never-smokers – no. (%) | 2960 (24)* | 40 292 (44) | 2026 (51)*,† |
Former smokers – no. (%) | 5096 (41) | 37 429 (41) | 1575 (40) |
Current smokers – no. (%) | 4276 (35)* | 13 851 (15) | 321 (8)*,† |
Unknown– no. (%) | 32 (<1)* | 366 (<1) | 22 (<1)† |
Tobacco consumption – pack-years‡ | 30·0 (15·0–44·0)* | 14·8 (5·3–27·7) | 7·5 (2·8–15·0)*,† |
Poor socioeconomic status – no. (%) | 3634 (29)* | 15 161 (16) | 524 (13)*,† |
Asthma – no. (%) | 1935 (16)* | 4519 (5) | 104 (3)*,† |
Treatment with airway medication – no. (%) | 2359 (19)* | 4048 (4) | 94 (2)*,† |
Data presented as median (25th and 75th percentiles), or number (percent). Numbers may not sum to 100 due to rounding. Based on the Copenhagen General Population Study. BMI=body mass index. FEV1=forced expiratory volume in 1 sec. FVC=forced vital capacity.
P < 0·05 for comparison with normal lung function using Wilcoxon's rank sum or Pearson's chi-squared test.
P < 0·05 for comparison with below normal lung function using Wilcoxon's rank sum or Pearson's chi-squared test.
Includes only current and former smokers.